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Abstract
Background: The initial placement of orthodontic elastomeric separators can be uncomfortable and painful.
Therefore, it is important to relieve this disturbing sensation to create a discomfort or pain-free orthodontic visit.
The purpose of this study was to investigate the effect of a lidocaine/prilocaine topical anesthetic on pain and
discomfort associated with the placement of orthodontic elastomeric separators.
Methods: Fifty subjects aging between 20–35 years were included in this study. In the maxillary arch, a lidocaine/
prilocaine topical anesthetic was placed around the ginigval margins of the premolar and molar on side. On the
other side, a placebo agent was placed around the ginigval margins of the premolar and molar. After two minutes,
an elastomeric separator was placed between the premolar and molar on both sides. The subjects were then asked
to report their findings on a Verbal Scale and a Visual Analogue Scale every second minute for a period of 10 min.
The subjects were also given a questionnaire to evaluate the overall impression on the topical anesthetic use.
Results: The overall mean discomfort/pain score was found to be significantly lower (p < 0.001) with the topical
anesthetic than with the placebo. Repeated measures ANOVA with a Greenhouse-Geisser correction determined
that mean pain scores were statistically significantly low with the 10-min time duration (F(1.54,42.2) = 40.7, p = 0.001),
with an estimated grand mean (8.37, 95% CI 6.75–9.98). The questionnaire responses revealed that 87% of the
subjects reported an overall satisfaction and agreement with the topical anesthetic than with the placebo or no
difference (13%) after the initial separator placement.
Conclusions: The discomfort and pain resulting from the initial placement of orthodontic elastomeric separators
can be significantly reduced with the lidocaine/prilocaine topical anesthetic.
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Background
Orthodontic discomfort and pain can be disadvanta-
geous to the patient’s compliance and response to treat-
ment. This unpleasant experience may occasionally
cause loss of interest, poor compliance, compromised
treatment results, and even eventual termination of
treatment [1, 2]. The various painful and distressing
orthodontic procedures include separator placement,
archwire insertion and activation, application of ortho-
pedic forces, use of elastics, and debonding procedures
[3]. The accompanying uncomfortable sensations experi-
enced by patients during orthodontic treatment are
often described as feelings of pressure, tightness, sore-
ness of the teeth, and pain [4].
It was demonstrated in some studies that amongst the
discomfort and pain causing orthodontic procedures is
the placement of separators, which can be elastomeric,
brass wire, spring type, steel, and latex separators [4–6].
These studies have reportedly shown that discomfort
was clearly associated with separator placement. The
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sensation of discomfort often starts within 4 h of separ-
ator placement, gradually increasing over the next 24 h,
and then tends to decrease within 7 days [4, 5]. The
orthodontic patients’ response to the initial placement of
separators seems to be overlooked, and there is no
current information in the literature that analyzed the
patients’ initial response to such a procedure.
There are several methods for managing orthodontic
pain and discomfort that were covered in the literature.
The most common method used to manage orthodontic
pain and discomfort was the use of systemic analgesics
[5, 7–10]. Chewing on something hard such as a
chewing gum or a plastic wafer, during the first few
hours of appliance activation, has been recommended for
reducing the orthodontic pain [11–14]. Other methods
such as low-level laser therapy (LLLT), transcutaneous
electrical nerve stimulation (TENS), and vibratory
stimulation were also advocated for managing ortho-
dontic pain [13, 15–17].
Topical anesthetics have been used in different dental
procedures for reducing or eliminating pain. It was dem-
onstrated that pain from needle stick injections in the
maxillary vestibular and palatal mucosae could potently
be reduced or eliminated by using a combination of
2.5% lidocaine/2.5% prilocaine topical anesthetics in a
creamy eutectic mixture, known as EMLA® (EMLA,
AstraZeneca UK Limited, Bedfordshire), or a thermoset-
ting gel, known as Oraqix® (ORAQIX, DENTSPLY Inter-
national, PA, USA) [18–20]. Other studies reported
different useful applications of lidocaine, adrenaline, and
tetracaine (LAT) gel and EMLA® cream, such as suturing
of the facial and soft tissue lacerations and minor biop-
sies [17, 21–23]. One study concluded that lidocaine and
prilocaine topical anesthetics could be used in oral mu-
cosal lacerations prior to suturing without the risk of ad-
verse tissue reaction [24].
The effect of the lidocaine/prilocaine topical anesthetic
Oraqix® on pain reduction from orthodontic proce-
dures has been studied previously. The findings of
one study suggested the potential usefulness of
Oraqix® in performing orthodontic procedures such as
band placement and cementation, archwire ligation,
and band/bracket removal [25]. The advantage of the
topical anesthetic gel Oraqix® was its delivery method,
which simply introduced the gel into the gingival
crevice. The suggested indication for use was corre-
lated with the reduction of pain during scaling in gin-
gival pockets. The gel hardened with intraoral
temperature and hence was easily contained within
the gingival crevice. Also, the application procedure
was reportedly simple and completely painless [26].
Since Oraqix® has not yet been used for discomfort
and pain relief from the initial elastomeric separator
placement, extending the use of Oraqix® to relieve
patients from the associated sensation of discomfort would
be an interesting achievement.
This study was aimed at comparing the topical
anesthetic effect of a 2.5% lidocaine/2.5% prilocaine gel
(Oraqix®) with a Vaseline® placebo on the reduction of
discomfort and pain from the initial placement of ortho-
dontic elastomeric separators.
Methods
Fifty subjects, between 20 and 35 years of age, were in-
cluded in this study, 47 females and 3 males. The subjects
were undergraduate fifth- and sixth-year dental students,
staff members, and dental assistants from the Faculty of
Dentistry, Kuwait University. A written consent was ob-
tained from all subjects participating in this study. The
study’s experimental design and protocol were approved
by the Ethical Committee of the Health Sciences Center,
Kuwait University.
The inclusion criteria of this study involved the pres-
ence of healthy gingival tissues, complete intact poster-
ior occlusion, intact maxillary dentition with the
exception of the third molars, and tight contacts be-
tween the posterior teeth which was checked with a
piece of floss. The exclusion criteria comprised of the
existence of inflamed gingival tissues and periodontal
disease, missing posterior teeth, spacing between the
posterior dentition, retained deciduous posterior teeth,
and interproximal carious lesions and/or restorations be-
tween the first molar and the second premolar. Subjects
with systemic diseases and/or are taking systemic anal-
gesics were excluded from the study.
Only the subjects were blinded during the study by
wearing sunglasses with gauze taped to the inner side of
the shades. The gingival tissues of the first molars and the
second premolars from both sides of the maxillary arch
were first dried using gauze and the air-water syringe. A
suction device and cotton rolls were used to achieve a dry
field prior to the application of agents and throughout the
procedure. The subjects had their mouths open during
the entire experimental procedure. This was done to pre-
vent accidental distribution of the topical anesthetic, Ora-
qix®, to the placebo, Vaseline®, side.
A split-mouth design was applied. On one side, using
an Oraqix® dispenser and a blunt dispensing needle, the
Oraqix® gel was injected around the gingival margins
and into the crevices of the first molar and the second
premolar (Figs. 1 and 2). The procedure of dispensing
the topical anesthetic gel was non-invasive and entirely
painless as the gel was applied directly to the soft tissue
of the periodontal pocket, and it was allowed to saturate
into the gingival crevice.
A few drops of Oraqix® were applied on the orthodon-
tic elastomeric separator (Ormco Separators, Ormco
Corporation, CA) prior to its placement between the
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teeth to ensure that the topical anesthetic agent reached
the interproximal tissues adequately without the need to
use a dispensing needle, which may cause discomfort or
pain. Moreover, Oraqix® is a liquid gel when first applied,
which is difficult to contain within the gingival tissues,
unlike Vaseline® (Vaseline®, 100% pure petroleum jelly,
Unilever, USA), which is more viscous and easily con-
tained on and within the gingival tissues. In addition,
placing a few drops of Oraqix® on the separator before
its placement between the teeth did not facilitate its in-
sertion as the contact points between the teeth which
were tight to begin with.
On the contralateral side, using an irrigation syringe
with a blunt applicator tip, a small size amount of placebo
Vaseline® was placed around the gingival margins of the
first molar and the second premolar (Figs. 1 and 2). The
sides, where the materials were applied, were randomly al-
ternated in such a way that if the first subject received
Oraqix® on the right side, then the next subject had it on
the left side and so on. At the end of the study, half of the
subjects received Oraqix® on the right side and the other
half had it on the left side.
After 2 min from the application of the agents on both
sides, the orthodontic elastomeric separator was stretched,
using two pieces of floss, and placed between the first
molar and the second premolar on both sides (Fig. 3). The
subjects were requested to immediately report the degree
of pain on both a visual analogue scale (VAS) and a verbal
scale. The overall pain was measured by the subjects by
means of a 100-mm horizontal non-graded VAS, with the
left endpoint marked as “no discomfort/pain,” and the
right endpoint marked “worst possible discomfort/pain,”
as the primary efficacy parameter. A verbal rating scale,
which permitted the subject to make a direct comparative
assessment on asking which side was least painful, was
used as a secondary efficacy parameter. The subjects had
three choices to select from that included “right side,” “left
side,” or “no difference.” The subjects’ responses were
Fig. 1 a Side-by-side view of the materials used: on the right side, the Oraqix® vial and its dispensing syringe, and on the left side, the Vaseline®
and the syringe used for its application. b Side-by-side view of the syringes loaded with the materials and the blunt application needles installed
Fig. 2 Intraoral photograph. An upper frontal view of the maxillary
arch showing the materials placed around the gingival margins and
into the crevices of the maxillary first molar and second premolar on
both sides. On the upper right side, the topical anesthetic (TA)
Oraqix® was placed. Oraqix® is a transparent and colorless material
which is difficult to view in the photograph. On the left side, the
placebo (Vaseline®) was placed
Fig. 3 Intraoral photograph. An upper occlusal view showing the
orthodontic elastomeric separators placed between the maxillary
second premolars and first molars
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recorded every second minute for a total period of
10 min. At the end of the study, the separators were re-
moved and the subjects were asked to rinse their mouths
with water to wash off the materials applied.
A questionnaire was given to the subjects and was
returned the following day. The survey contained com-
parative questions about the overall satisfaction, taste,
numbing effect, presence of numbness after 30 min, per-
sonal preference, recommendation for routine use in
orthodontic clinics, recommendation for application on
adults and children, and the experience of any adverse
reactions the following day.
Statistical analysis
The data management, analysis, and graphical presenta-
tion were carried out using the computer software, “Stat-
istical Package for Social Sciences, SPSS version 22.0”
(IBM Corp., Armonk, NY, USA). The descriptive statis-
tics for all the subjects reporting least pain sensation
when comparing both sides have been presented as
numbers and percentages, and the continuous variable,
percent pain sensation as mean ± standard deviation
(SD). The general linear model (GLM) for repeated mea-
sures ANOVA was applied to see within-subject effect at
five different durations of time, from 2 min until 10 min,
as well as the between-subject factor, placebo (Vaseline®)
and topical anesthetic (Oraqix®). Greenhouse-Geisser
correction was applied as the Mauchly’s test of sphericity
was not met. The estimated marginal means are also re-
ported with 95% confidence interval (CI). The two-tailed
probability value p < 0.05 was considered statistically
significant.
Results
Comparison of visual analogue scores (VAS)—Table 1 and
Figs. 4 and 5
The percent pain sensation was assessed on the topical
anesthetic (TA), Oraqix®, side and the placebo, Vaseline®,
side using VAS. In comparison with Vaseline®, Oraqix®
significantly reduced discomfort/pain (Fig. 4). Although
the discomfort/pain scores were reduced with time in
both placebo and TA sides, the TA discomfort/pain re-
duction was significantly better than the placebo. The
significant difference was seen from the sixth minute
onward. A similar pattern of discomfort/pain response
was observed for almost all of the 50 subjects on the pla-
cebo side and on the TA side (Fig. 5). A gradual fall in the
pain scores was noticed with time duration. Repeated
measures ANOVA with a Greenhouse-Geisser correction
determined that the mean pain scores improved statisti-
cally significantly with the time duration (F(1.54,42.2) = 40.7,
p = 0.001), with an estimated grand mean (8.37, 95% CI
6.75–9.98) (Table 1). Also, a significant difference was
found in the pain level between TA and placebo (F = 29.2,
p < 0.001). The estimated marginal mean pain with TA
(3.96, 95% CI 1.67–6.25) was significantly less compared
to placebo (12.77, 95% CI 10.48–15.06) (Table 1).
Least painful side as reported verbally (verbal
scale)—Table 2 and Fig. 5
The mean pain sensation scores were significantly lower
on the TA side than on the placebo side, at all of the 2-min
intervals (Table 2). The verbal scale results revealed that
the topical anesthetic agent, Oraqix®, reduced pain signifi-
cantly better than the placebo, Vaseline®, every 2 min for
10 min. This significant difference was clearly seen from
the sixth minute onwards (Fig. 5). Overall, 82% of the sub-
jects reported least pain on the TA side, while 4.4% of them
mentioned less pain on the placebo side, and the remaining
13.6% felt no difference between both sides.
At 2 min, 38 subjects reported less pain on the TA
side, eight subjects described the placebo side as the
least painful side, and four subjects stated no difference
between the sides. After 4 min, 40 subjects reported less
pain on the TA side, three subjects reported less pain on
the placebo side, and seven subjects reported no differ-
ence between the sides. After 6 min, 43 subjects felt de-
creased pain on the TA side, none described the placebo
side as the least painful side, and seven subjects reported
no difference between the sides. At the eighth and tenth
minutes, 42 subjects reported that the TA side was the
least painful side, none of the subjects reported the pla-
cebo side as the least painful side, and eight subjects
stated no difference between the sides.
Satisfaction level and opinion on TA use (questionnaire
responses)—Table 3
1. Overall satisfaction
Table 1 Mean percent pain scores on visual analogue scale (VAS) with estimates ANOVA with repeated measures (RM)
Duration (minutes) Number Mean ± SD (TA) Mean ± SD (Placebo) Estimated grand mean (95% CI) p value (ANOVA RM)
2 50 11.53 ± 11.27 20.91±20.74 16.22 (12.91–19.53)
4 50 4.52 ± 7.40 14.99±13.23 9.76 (7.63–11.88) F = 40.7
6 50 2.65 ± 6.10 11.79±11.13 7.22 (5.44–9.00) (p = 0.001)
8 50 0.80 ± 2.79 8.90 ± 9.37 4.85 (3.48–6.22)
10 50 0.30 ± 0.95 7.27±10.12 3.78 (2.36–5.12)
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With regards to the overall satisfaction, 47 subjects
reportedly felt more pleasant with the side of the
topical anesthetic, and three patients reported no
difference between the sides.
2. Taste
Regarding the taste preference, 15 subjects reported
better taste from the topical anesthesia side, 30
subjects preferred the taste from the placebo side,
and five subjects reported no taste difference
between both sides.
3. Numbing effect
Concerning the numbing effect, all 50 subjects
reported intense numbness on the side of the
topical anesthetic.
Fig. 4 Visual analogue scale (VAS). VAS scores (%) at different times (minutes) after the application of topical anesthetic (TA Oraqix®) and
placebo (Vaseline®)
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4. Presence of numbness after 30 min
The subjects were asked to report any sensation of
numbness after 30 min from completing the study.
The data showed that 35 subjects experienced
slight numbness remaining on the side of the
topical anesthetic and 15 subjects reported no
numbness after 30 min.
5. Personal preference
Regarding the personal recommendation, all 50
subjects preferred the side that contained the
topical anesthetic as the material desired for
them if they were to receive separators in the
future.
6. Recommendation for use in orthodontic clinics
For use in orthodontic clinics, all 50 subjects
favored the TA side and suggested the use of that
material as a routine for orthodontic separator
placement.
7. Recommendation for adults and children
All 50 subjects preferred the topical anesthetic side
as the material of choice for apprehensive adults
and children.
8. Adverse effects
The subjects were asked to report any adverse
reactions experienced after 1 day from the
application of the materials. All 50 subjects reported
no adverse reactions of any kind the following day.
Discussion
The results of this study showed that topical anesthesia
could be a valuable tool in reducing pain and discom-
fort associated with several orthodontic procedures.
The lidocaine/prilocaine topical anesthetic, Oraqix®,
could be effective in relieving pain and discomfort re-
lated to the initial placement of orthodontic elastomeric
separators.
Based on clinical experience, the placement of ortho-
dontic separators in some patients can cause immediate
initial pressure, leading to discomfort and/or pain as
soon as the separator is wedged between the teeth. The
patients’ degree of initial and delayed responses to the
uncomfortable and painful orthodontic procedures can
be attributed to several factors, including age, gender,
and pain threshold, which can affect the patients’ motiv-
ation for orthodontic treatment [3, 14, 27]. Therefore,
some orthodontic patients do need special consideration,
making it imperative to find a method that decreases the
patients’ initial discomfort and pain during the separator
placement visit to ensure good compliance in the ortho-
dontic visits.
The use of topical anesthetics was found to be in-
volved in various orthodontic procedures for relieving
discomfort and pain. A study, for instance, reported the
Fig. 5 Verbal scale. A graphic representation showing the least
painful side as reported by the subjects favoring either the
topical anesthetic (TA Oraqix®) side or the placebo (Vaseline®)
side or reporting no difference between both sides
(no difference)
Table 2 The verbal scale displaying the number (no.) and percentage (%) of subjects reporting the placebo (Vaseline) side as the
least painful side, the topical anesthesia (TA), Oraqix, side as the least painful side, and no difference between both sides concerning






No. (%) No. (%) No. (%)
2 8 (16.0) 38 (76.0) 4 (8.0)
4 3 (6.0) 40 (80.0) 7 (14.0)
6 0 (0) 43 (86.0) 7 (14.0)
8 0 (0) 42 (84.0) 8 (16.0)
10 0 (0) 42 (84.0) 8 (16.0)
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use of a benzocaine containing wax for the relief of oral
mucosal irritation caused by orthodontic fixed appli-
ances. In comparison with the unmedicated wax com-
monly used in orthodontic clinics, the benzocaine-
medicated wax was found to be instantly effective, and
its anesthetic effect kept increasing with time [28]. A
preliminary study analyzed the effect of benzocaine
mucoadhesive patches on orthodontic pain caused by
elastomeric separators. It was revealed that the use of
20% benzocaine patches during the first 3 days after the
separator placement significantly decreased the degree
of pain [29]. This finding triggered the interest to inves-
tigate the effect of the lidocaine/prilocaine topical
anesthetic, Oraqix®, on pain reduction from the initial
placement of orthodontic separators. It would also be in-
teresting to study the effect of Oraqix® on pain reduction
after hours or days from separator placement.
In this study, after applying Oraqix®, a waiting period
of 2 min was chosen before the placement of the separa-
tors. This was due to the potency of Oraqix® as previous
studies showed that it is efficient from the first 2 min
after application to the vestibular and palatal mucosae
[7–9]. Regarding the study’s duration, a total period of
10 min was selected as it usually takes less than 5 min
for placing the orthodontic elastomeric separators and
about 10 min is needed to give the instructions to the
patient or guardian and to answer their questions before
leaving the orthodontic clinic. It was best to have the
patient relieved of any disturbing sensation during the
visit to ensure proper attendance to appointments, good
compliance to treatment, and a pleasant in-office
experience.
Concerning the VAS results of this study, regardless of
the sides the materials were applied to, it was shown that
the Oraqix® side reduced discomfort/pain earlier and sig-
nificantly better than the Vaseline® side (Fig. 4). The sig-
nificant difference in the percentage of pain reduction
between both materials was evident from the fourth and
sixth minutes onwards. The early onset of action shown
in this study coincided with the findings from two previ-
ous studies that compared the anesthetic effect of two
lidocaine/prilocaine substances with benzocaine. Both
studies showed that the lidocaine/prilocaine substances
(EMLA® and Oraqix®) reduced pain significantly better
than benzocaine as early as the first and second minutes
after application [18–20]. In this study, after 2 min from
applying the materials, some subjects reported mostly
pressure and discomfort after the instant separator
placement, and this sensation was probably due to the
fact that 2 min was not sufficient enough to anesthetize
the gingival margins and periodontal ligament. This
could be due to the thickness of the gingival tissues as
well as the distance of penetration of the topical
anesthetic to anesthetize the periodontal ligament.
Moreover, due to the fact the subjects had different pain
thresholds, some subjects reported low pain scores,
while others reported higher pain scores during the en-
tire duration of the study.
The overall mean discomfort/pain score on the VAS
was found to be significantly lower (p < 0.001) with the
topical anesthetic (3.9 ± 0.49 SE) than with the placebo
(12.8 ± 0.90 SE) (Table 1). As observed from the VAS
graphs of both the placebo and TA sides, most sub-
jects described the sensation as pressure discomfort
giving lower percentages of discomfort/pain evalu-
ation, while a few reported a painful perception imme-
diately after the initial placement of the elastomeric
separators, and hence reported higher percentages of
discomfort/pain evaluation (Fig. 4). This supported
the previous findings that patients of different age,
gender, ethnicity, psychosocial background, and pain
tolerance and threshold could have varying responses
to discomfort and pain [14].
Some studies looked at pain from orthodontic tooth
separation by registering pain responses on a VAS at
three time points: T1 (before insertion of the tab), T2
(immediately after insertion), and T3 (24 h after inser-
tion) [30, 31]. In this study, the effect of the topical
Table 3 The questionnaire comprising of eight questions set for the subjects to answer after completion of the study
Question Placebo (Vaseline) side TA (Oraqix) side No difference
1. Which side was more pleasant (overall satisfaction)? 47 (94%) 3 (6%)
2. Which side tasted better? 30 (6%) 15 (30%) 5 (10%)
3. Which side was more numb? - 50 (100%) -
4. Which side felt more numb after 30 minutes? - 35 (70%) 15 (30%)
5. Which side do you prefer if you will have separators
placed for orthodontic treatment?
- 50 (100%) -
6. Which topical agent side would you recommend for
routine use at the orthodontic clinics?
- 50 (100%) -
7. Which topical agent side would you recommend for
children and adults?
- 50 (100%) -
8. Where there any adverse effects the next day? - 50 (100%) -
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anesthetic Oraqix® versus the placebo Vaseline® on dis-
comfort or pain from the very beginning of the place-
ment of the orthodontic elastomeric separators was
analyzed. It would be interesting to monitor the effect of
Oraqix® 24 h after insertion. However, this is difficult to
achieve this as the duration of action of Oraqix® is about
20 min in a dry field.
In this study, the verbal scale showed that most sub-
jects reported Oraqix® as the least painful side, and the
effect was evident from the second minute of application
(Table 2, Fig. 5). A few subjects did report less pain on
the placebo side after 2 and 4 min. Those subjects ex-
plained that the anesthetic effect was bothersome and ir-
ritating as it was too strong. When those subjects were
asked in detail about their dental history, some did men-
tion a bad dental experience in the past with anesthetic
needles, and that this sensation reminded them of this
disturbing perception. Moreover, throughout the dur-
ation of the study, a few subjects reported no difference
between the Vaseline® and Oraqix® sides with regard to
reduction of discomfort/pain perception after separator
placement. Regardless of their response in the verbal
scale, by the end of this study, the subjects still preferred
and recommended the use of Oraqix® for adults and
children in orthodontic clinics.
Regarding the overall satisfaction, a high number of
subjects felt more satisfied and pleasant with the Oraqix®
side as the pressure created from the separator was re-
lieved (Table 3). Some patients reported that the placebo
side felt like there was a piece of foreign object or meat
stuck between their teeth creating immediate pressure
that was very annoying.
The subjects’ response to the taste was inconsistent
(Table 3). More subjects seemed to favor the taste of pla-
cebo Vaseline®, which was tasteless, as opposed to the
taste of Oraqix®, which was bitter. A few patients were
confused which side tasted better as at the end of the
study, they could not remember the taste after rinsing
their mouths. Also, some of the subjects mentioned that
the whole oral cavity felt bitter, which meant that some
of the Oraqix® material might have been mixed with sal-
iva despite the vigilant use of saliva ejectors. Despite the
bitterness of Oraqix®, most subjects did favor the taste of
it. Again, most patients could not remember the differ-
ence of taste by the end of the study. In this study, the
bitter taste of Oraqix® coincided with a previous study
that compared the effect of two lidocaine/prilocaine sub-
stances, Oraqix® and EMLA®, on pain reduction after
palatal needle sticks. Both materials had the same com-
position, but EMLA® was a cream and Oraqix® existed as
a gel. The study showed that Oraqix® was more bitter
than EMLA® as reported by the subjects [20]. Hence,
since Oraqix® is FDA approved and registered for intraoral
use, it was essential to suggest a recommendation to the
manufacturer to improve the taste of Oraqix® to be more
acceptable by patients, particularly children.
All subjects reported more numbness on the Oraqix®
side, and the anesthetic effect was described as intense
(Table 3). Seventy percent of the subjects mentioned that
the anesthetic effect lingered with a reduced effect for
30 min after completion of the study, while 30% of the
subjects reported complete absence of anesthetic effect
after 30 min. As reported in one study about the onset
and duration of action as assessed by probing of pocket
depths, Oraqix® provided anesthesia after an application
time of 30 s, with a mean duration of action of about 17
to 20 min [32]. The anesthetic effect of Oraqix® might
eliminate the need for a preemptive administration of a
systemic analgesic, and it may possibly limit the patient
to only a postoperative dose of systemic analgesic after
the anesthetic effect wears off.
When the subjects were asked about their personal
preference, recommendation for routine use at ortho-
dontic clinics, and recommendation for use for adults
and children, all subjects reported the Oraqix® side as
the preferred side (Table 3). This suggested that even
though some subjects did report no difference between
the sides in terms of overall satisfaction, they still felt
that it would be of benefit for them as well as others.
Moreover, all subjects reported no adverse effects
experienced on both sides 1 day after the study (Table 3).
As concluded in one study, in terms of the systemic
effects after the application of Oraqix® in periodontal
pockets, there was a large safety margin. The plasma
profiles of lidocaine and prilocaine following a single
dose of Oraqix® to patients with advanced periodontitis
were low as compared to those reported to cause initial
signs of CNS toxicity [32].
In this study, there were some weaknesses that need to
be addressed in future studies. Increasing the sample size
and including more males would be advantageous besides
facilitating the investigation of the effect of age, gender,
ethnicity, and psychosocial factors on the outcome of
the subjects’ response to pain and discomfort related
to placement of orthodontic elastomeric separators. It
would also be motivating to explore new means to
extend the effect of topical anesthetics in relieving pain
and discomfort experienced after a couple of hours or
even a day from the placement of orthodontic elastomeric
separators.
Conclusions
This study showed that the lidocaine/prilocaine topical
anesthetic, Oraqix®, could potently relieve discomfort or
pain experienced after the initial placement of the ortho-
dontic elastomeric separators. This method could be
useful for patients with a low pain threshold as well as
apprehensive adults and children.
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